Reviva Pharmaceuticals HoldiRVPH
13F holders, Q3 2025 (September 30)1holders
$0.79avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Reviva Pharmaceuticals Holdi (RVPH) in their 13F filings. The largest holder was Sound Income Strategies, LLC ($24K).
- Company
- Reviva Pharmaceuticals Holdi
- CUSIP
- G8708A116
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $24K |
| Exits | 0 | $0 |
Ownership 1 holders
| Sound Income Strategies, LLC | 0.00% | New | 30,000 | $24K |
"% of holder's portfolio" is RVPH's weight in each manager's 13F, not the share of Reviva Pharmaceuticals Holdi the manager owns.